Nascent Biotech, Inc. (NBIO)

USD 0.0

(0.0%)

Total Debt Summary of Nascent Biotech, Inc.

  • Nascent Biotech, Inc.'s latest annual total debt in 2024 was 122.5 Thousand USD , down -68.56% from previous year.
  • Nascent Biotech, Inc.'s latest quarterly total debt in 2024 FY was 122.5 Thousand USD , down -68.56% from previous quarter.
  • Nascent Biotech, Inc. reported annual total debt of 389.59 Thousand USD in 2023, down 0.0% from previous year.
  • Nascent Biotech, Inc. reported annual total debt of - USD in 2022, down -100.0% from previous year.
  • Nascent Biotech, Inc. reported quarterly total debt of 276.97 Thousand USD for 2024 Q1, down -28.91% from previous quarter.
  • Nascent Biotech, Inc. reported quarterly total debt of 122.5 Thousand USD for 2024 FY, down -68.56% from previous quarter.

Annual Total Debt Chart of Nascent Biotech, Inc. (2024 - 2013)

Historical Annual Total Debt of Nascent Biotech, Inc. (2024 - 2013)

Year Total Debt Total Debt Growth
2024 122.5 Thousand USD -68.56%
2023 389.59 Thousand USD 0.0%
2022 - USD -100.0%
2021 161.73 Thousand USD 16.51%
2020 138.81 Thousand USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD -100.0%
2015 60 Thousand USD 0.0%
2014 - USD -100.0%
2013 151.62 Thousand USD 0.0%

Peer Total Debt Comparison of Nascent Biotech, Inc.

Name Total Debt Total Debt Difference
Bioxytran, Inc. 1.92 Million USD 93.636%
Eiger BioPharmaceuticals, Inc. 41.2 Million USD 99.703%
Institute of Biomedical Research Corp. 401.84 Thousand USD 69.516%
SQZ Biotechnologies Company 27.47 Million USD 99.554%
Intellipharmaceutics International Inc. 2.32 Million USD 94.733%
Evofem Biosciences, Inc. 43.37 Million USD 99.718%
Santhera Pharmaceuticals Holding AG 29.76 Million USD 99.588%
Propanc Biopharma, Inc. 948.27 Thousand USD 87.082%
Marizyme, Inc. 18.71 Million USD 99.346%
Genus plc 233.1 Million USD 99.947%
Pharming Group N.V. 171.54 Million USD 99.929%
Therapeutic Solutions International, Inc. 888.06 Thousand USD 86.206%
CNBX Pharmaceuticals Inc. 1.34 Million USD 90.883%
Nymox Pharmaceutical Corporation 750 Thousand USD 83.667%
ContraFect Corporation 2.88 Million USD 95.748%
RegeneRx Biopharmaceuticals, Inc. 1.44 Million USD 91.53%
IMV Inc. 28.88 Million USD 99.576%
AXIM Biotechnologies, Inc. 5.65 Million USD 97.835%
ONE Bio Corp. 19.71 Million USD 99.379%
RVL Pharmaceuticals plc 57.48 Million USD 99.787%
Mesoblast Limited 118.7 Million USD 99.897%
MultiCell Technologies, Inc. 202.58 USD -60369.938%
Arno Therapeutics, Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 33.1 Million USD 99.63%
Genscript Biotech Corporation 417.73 Million USD 99.971%
Neon Bloom, Inc. 630.07 Thousand USD 80.558%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 90.027%
Nanobac Pharmaceuticals, Incorporated 4.12 Million USD 97.028%
Biomind Labs Inc. 735.54 Thousand USD 83.346%
Provectus Biopharmaceuticals, Inc. 3.02 Million USD 95.952%
Oncotelic Therapeutics, Inc. 12.99 Million USD 99.057%
Skye Bioscience, Inc. 4.61 Million USD 97.346%
GlobeStar Therapeutics Corporation 359.71 Thousand USD 65.945%
VioQuest Pharmaceuticals, Inc. 2.93 Million USD 95.82%
THC Farmaceuticals, Inc. 141.51 Thousand USD 13.439%
PsyBio Therapeutics Corp. 135.48 Thousand USD 9.585%
Arch Therapeutics, Inc. 5.87 Million USD 97.914%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 25.71 Thousand USD -376.302%
Accustem Sciences Inc. - USD -Infinity%
EV Biologics, Inc. 1.49 Million USD 91.805%
Q BioMed Inc. 4.1 Million USD 97.019%
GB Sciences, Inc. 1.75 Million USD 93.037%
Alpha Cognition Inc. 1.22 Million USD 89.962%
CSL Limited 12.18 Billion USD 99.999%
Agentix Corp. 50 Thousand USD -145.0%
American Oriental Bioengineering, Inc. 67.64 Million USD 99.819%
Enzolytics Inc. 996.33 Thousand USD 87.705%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Resverlogix Corp. 6.49 Million USD 98.113%
Nuo Therapeutics, Inc. 255.59 Thousand USD 52.072%
MetaStat, Inc. - USD -Infinity%
Curative Biotechnology, Inc. 2.25 Million USD 94.576%
argenx SE 20 Million USD 99.388%
Northwest Biotherapeutics, Inc. 45.56 Million USD 99.731%
HST Global, Inc. 98.31 Thousand USD -24.594%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Wesana Health Holdings Inc. 248.72 Thousand USD 50.748%
Halberd Corporation 150 Thousand USD 18.333%
Endonovo Therapeutics, Inc. 7.07 Million USD 98.268%
Inhibitor Therapeutics, Inc. - USD -Infinity%
Zenith Capital Corp. 10.22 Thousand USD -1098.044%
RespireRx Pharmaceuticals Inc. 2.7 Million USD 95.478%
GeneThera, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 2.39 Million USD 94.891%
AVAX Technologies, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. 229.29 Thousand USD 46.574%
Cotinga Pharmaceuticals Inc. 148.65 Thousand USD 17.594%
Ember Therapeutics, Inc. 200.61 Thousand USD 38.938%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
NovAccess Global Inc. 2.19 Million USD 94.432%
Helix BioMedix, Inc. - USD -Infinity%
Capstone Therapeutics Corp. 20.32 Million USD 99.397%
Kadimastem Ltd 891.22 Thousand USD 86.255%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
BioStem Technologies, Inc. 4.71 Million USD 97.4%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 250.18 Thousand USD 51.036%
Burzynski Research Institute, Inc. - USD -Infinity%
LadRx Corporation 33.6 Thousand USD -264.518%
Cell Source, Inc. 9.25 Million USD 98.676%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 756.2 Thousand USD 83.801%
Regen BioPharma, Inc. 756.2 Thousand USD 83.801%
Affymax, Inc. - USD -Infinity%
Mobile Lads Corp. 484.28 Thousand USD 74.705%
Itoco Inc. 228.37 Thousand USD 46.361%
Rasna Therapeutics, Inc. 210.97 Thousand USD 41.936%
Pathfinder Cell Therapy, Inc. 4.98 Million USD 97.542%
International Stem Cell Corporation 4.17 Million USD 97.068%
CytoDyn Inc. 30.07 Million USD 99.593%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 351.84 Thousand USD 65.184%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 98.433%
SYBLEU INC 477.5 Thousand USD 74.346%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Rebus Holdings, Inc. 310 Thousand USD 60.484%
GlobeImmune, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 4.73 Million USD 97.413%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. 62.41 Thousand USD -96.273%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. 2.18 Million USD 94.383%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.31 Million USD 98.527%
Adhera Therapeutics, Inc. 8.58 Million USD 98.573%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. 1.55 Million USD 92.125%
Innovation Pharmaceuticals Inc. 268 Thousand USD 54.291%
Neutra Corp. 54.15 Thousand USD -126.198%
Windtree Therapeutics, Inc. 1.83 Million USD 93.306%
PureTech Health plc 25.51 Million USD 99.52%
Coeptis Therapeutics, Inc. 1.22 Million USD 89.994%
IXICO plc 472.02 Thousand USD 74.048%
IntelGenx Technologies Corp. 15.5 Million USD 99.21%
Gelesis Holdings, Inc. 62.26 Million USD 99.803%
CSL Limited 12.18 Billion USD 99.999%
Cellectis S.A. 92.77 Million USD 99.868%